NCT03898960View on ClinicalTrials.gov

Post Marketing Study to Evaluate the NIMBUS Device

CompletedOBSERVATIONAL
Enrollment

54

Participants

Timeline

Start Date

October 30, 2019

Primary Completion Date

February 15, 2022

Study Completion Date

April 8, 2022

Conditions
Cerebral Stroke
Interventions
DEVICE

NIMBUS Device

NIMBUS Geometric Clot Extractor

Trial Locations (2)

Unknown

UKE Hamburg, Hamburg

Karolinska Institute, Stockholm

All Listed Sponsors
lead

Neuravi Limited

INDUSTRY

NCT03898960 - Post Marketing Study to Evaluate the NIMBUS Device | Biotech Hunter | Biotech Hunter